The latter study did not include PAX3 in their list of genes upregulated in BSG, however, potentially due to the inclusion of thalamic gliomas in their high-grade glioma group, some of which could harbor high PAX3 expression. This evidence concerns the gene PAX3 and central nervous system cancer.